Type 1 Diabetes REst for Metabolic Health

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 12, 2025

Primary Completion Date

May 31, 2029

Study Completion Date

August 31, 2029

Conditions
Type 1 Diabetes (T1D)Sleep Health
Interventions
BEHAVIORAL

Sleep Health and Circadian Timing Intervention

Participants will be prescribed a sleep schedule that allows them to obtain at least 1h more time in bed compared to their typical school week schedule. In addition, participants will be provided with pharmaceutical-grade exogenous melatonin and instructed to take 500mcg 2 hours before their scheduled bedtime. They will also be asked reduce evening light exposure starting 2 hours before bedtime by limiting household lights and dimming electronics. In the mornings, participants will be exposed to bright light for 30 minutes after waking by wearing provided ReTimer light therapy glasses.

Trial Locations (1)

80045

RECRUITING

Children's Hospital Colorado, Aurora

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Colorado, Denver

OTHER